Xconomy Boston

Seaside Therapeutics Secures $30,000,000 New Round

  • Feed Type
  • Date
    9/17/2009
  • Company Name
    Seaside Therapeutics
  • Mailing Address
    840 Memorial Drive Cambridge, MA 02139
  • Company Description
    Seaside founders understand the toll that brain development disorders, including autism and mental retardation, take on families and share the sense of frustration that effective therapeutics are still not available despite recent scientific advances. Seaside Therapeutics was founded to fill this void and to develop potential treatments for these underserved populations by translating breakthrough discoveries in neurobiology into therapeutics that improve the lives of patients and their families.
  • Website
    http://www.seasidetherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The financing will be used to fund the Company’s pipeline of novel therapeutic candidates to correct or improve the course of those who suffer these disorders.
  • M&A Terms
  • Venture Investor
    Undisclosed

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.